Hydroxychloroquine is an immunomodulatory agent used primarily in malaria, lupus erythematosus, and rheumatoid arthritis. The authors summarize the potential proarrhythmic effect of this formulation and the key signs of drug-induced long QT syndrome. The topicality of the present summary is given by the more frequent use of hydroxychloroquine (currently without evidence) in the COVID-19 epidemic. Orv Hetil. 2020; 161 (17): 689-691.